Efficient expansion and dopaminergic differentiation of human fetal ventral midbrain neural stem cells by midbrain morphogens

[1]  D. Surmeier,et al.  Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD , 2011, Nature.

[2]  M. Horne,et al.  Wnt5a Regulates Midbrain Dopaminergic Axon Growth and Guidance , 2011, PloS one.

[3]  R. Jaenisch,et al.  Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats , 2010, Proceedings of the National Academy of Sciences.

[4]  Marios Politis,et al.  Serotonergic Neurons Mediate Dyskinesia Side Effects in Parkinson’s Patients with Neural Transplants , 2010, Science Translational Medicine.

[5]  E. Arenas,et al.  Emerging roles of Wnts in the adult nervous system , 2010, Nature Reviews Neuroscience.

[6]  Alberto Martínez-Serrano,et al.  In Vitro and in Vivo Enhanced Generation of Human A9 Dopamine Neurons from Neural Stem Cells by Bcl-XL* , 2010, The Journal of Biological Chemistry.

[7]  Alberto Martínez-Serrano,et al.  Generation and properties of a new human ventral mesencephalic neural stem cell line. , 2009, Experimental cell research.

[8]  G. Nikkhah,et al.  Combined use of BDNF, ascorbic acid, low oxygen, and prolonged differentiation time generates tyrosine hydroxylase-expressing neurons after long-term in vitro expansion of human fetal midbrain precursor cells , 2008, Experimental Neurology.

[9]  O. Isacson,et al.  Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease. , 2008, Brain : a journal of neurology.

[10]  R. Jaenisch,et al.  Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease , 2008, Proceedings of the National Academy of Sciences.

[11]  O. Lindvall,et al.  Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice. , 2008, The Journal of clinical investigation.

[12]  F. Edwards,et al.  Differential development of neuronal physiological responsiveness in two human neural stem cell lines , 2007, BMC Neuroscience.

[13]  G. Schulte,et al.  Wnt-5a induces Dishevelled phosphorylation and dopaminergic differentiation via a CK1-dependent mechanism , 2007, Journal of Cell Science.

[14]  Joris van Arensbergen,et al.  Enhanced Yield of Neuroepithelial Precursors and Midbrain‐Like Dopaminergic Neurons from Human Embryonic Stem Cells Using the Bone Morphogenic Protein Antagonist Noggin , 2007, Stem cells.

[15]  Mesencephalic human neural progenitor cells transplanted into the neonatal hemiparkinsonian rat striatum differentiate into neurons and improve motor behaviour , 2006, Journal of anatomy.

[16]  A. Storch,et al.  Uracil nucleotides stimulate human neural precursor cell proliferation and dopaminergic differentiation: involvement of MEK/ERK signalling , 2006, Journal of neurochemistry.

[17]  M. Beal,et al.  Functional engraftment of human ES cell–derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes , 2006, Nature Medicine.

[18]  H. Okano,et al.  Dynamic temporal and cell type-specific expression of Wnt signaling components in the developing midbrain. , 2006, Experimental cell research.

[19]  J. Qin,et al.  The controlled differentiation of human neural stem cells into TH-immunoreactive (ir) neurons in vitro , 2005, Neuroscience Letters.

[20]  A. Dagher,et al.  Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. , 2005, Brain : a journal of neurology.

[21]  G. Schulte,et al.  Purified Wnt‐5a increases differentiation of midbrain dopaminergic cells and dishevelled phosphorylation , 2005, Journal of neurochemistry.

[22]  Anders Björklund,et al.  Cell transplantation in Parkinson's disease: how can we make it work? , 2005, Trends in Neurosciences.

[23]  Xiaomin Wang,et al.  Forskolin cooperating with growth factor on generation of dopaminergic neurons from human fetal mesencephalic neural progenitor cells , 2004, Neuroscience Letters.

[24]  M. Beal,et al.  Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice , 2003, Nature Biotechnology.

[25]  Vesna Sossi,et al.  A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease , 2003, Annals of neurology.

[26]  P. Brundin,et al.  Effect of Mutant α-Synuclein on Dopamine Homeostasis in a New Human Mesencephalic Cell Line* , 2002, The Journal of Biological Chemistry.

[27]  R. McKay,et al.  Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease , 2002, Nature.

[28]  P. Sanberg,et al.  Neural transplantation for treatment of Parkinson's disease. , 2002, Drug discovery today.

[29]  R. McKay,et al.  In vitro generation and transplantation of precursor‐derived human dopamine neurons , 2001, Journal of neuroscience research.

[30]  Johannes Schwarz,et al.  Long-Term Proliferation and Dopaminergic Differentiation of Human Mesencephalic Neural Precursor Cells , 2001, Experimental Neurology.

[31]  C. Olanow,et al.  Transplantation of embryonic dopamine neurons for severe Parkinson's disease. , 2001, The New England journal of medicine.

[32]  H. Zoghbi,et al.  Neurobiology of disease , 2000, Current Opinion in Neurobiology.

[33]  K. Mizuseki,et al.  Induction of Midbrain Dopaminergic Neurons from ES Cells by Stromal Cell–Derived Inducing Activity , 2000, Neuron.

[34]  R. McKay,et al.  Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells , 2000, Nature Biotechnology.

[35]  Ornella Rimoldi,et al.  Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient , 1999, Nature Neuroscience.

[36]  A. Graybiel,et al.  The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. , 1999, Brain : a journal of neurology.

[37]  P R Sanberg,et al.  Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. , 1995, The New England journal of medicine.